Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues.
Since the discovery of spliceosome mutations in myeloid malignancies, abnormal pre-mRNA splicing, which has been well studied in various cancers, has attracted novel interest in hematology.
- Ref: doi: 10.3390/cancers12082216
- Année de publication : 2020
- Auteurs : Hautin M, Mornet C, Chauveau A, Bernard D, Corcos L, Lippert E.
- Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs »